R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study. (2025)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2666-5247(24)00083-1
PubMed Identifier: 39805301
Publication URI: http://europepmc.org/abstract/MED/39805301
Type: Journal Article/Review
Parent Publication: The Lancet. Microbe
ISSN: 2666-5247